Duration of Aygestin for Menstrual Delay
Aygestin (norethindrone acetate) can be taken for 10-15 days to delay a menstrual period, typically starting in the mid-to-late luteal phase of the cycle (around days 16-25 of a 28-day cycle).
Evidence-Based Dosing Duration
While the provided evidence does not contain specific FDA labeling for Aygestin's use in menstrual delay, the research on medroxyprogesterone acetate (MPA)—a related progestogen—provides the most relevant clinical guidance for progestogen-based menstrual manipulation.
Standard Treatment Duration
The most recent high-quality evidence suggests:
- 10-day protocol: MPA administered from days 16-25 of the menstrual cycle was more effective than longer durations for regulating menstrual cycles and controlling abnormal uterine bleeding 1
- 15-day protocol: MPA given from days 11-25 was also effective but required more cycles to achieve bleeding control 1
The 10-day regimen (starting mid-luteal phase) appears superior for menstrual regulation, requiring fewer treatment cycles to achieve desired outcomes 1.
Clinical Application
For menstrual delay specifically:
- Begin progestogen therapy before the expected period (ideally 3-5 days before anticipated menstruation)
- Continue daily until the desired delay period ends
- Withdrawal bleeding typically occurs 2-7 days after stopping the medication
- Maximum continuous use should generally not exceed 2-3 weeks to avoid endometrial complications
Important Caveats
Safety Considerations
- Prolonged use concerns: Extended MPA exposure (>4 years) or initiation after age 31 carries increased meningioma risk 2, though this applies primarily to depot formulations
- Not for routine use: This is an occasional intervention, not a regular contraceptive strategy
- Pregnancy must be excluded before initiating therapy
Common Pitfalls
- Starting too late in the cycle (after ovulation has already triggered the luteal phase cascade) reduces effectiveness
- Expecting immediate bleeding cessation—the medication prevents the next period, not an ongoing one
- Using this approach monthly, which may reduce contraceptive effectiveness if combined hormonal contraceptives are being manipulated 3
Practical Limitations
The evidence base specifically for norethindrone acetate (Aygestin) in menstrual delay is limited. The recommendations extrapolate from MPA data 1 and general progestogen physiology. A 10-14 day course starting in the predicted luteal phase represents the most evidence-supported approach, balancing efficacy with minimal exposure duration.